Ibuprofen Linked To Reduced Alzheimer's Risk

Researchers in the US studying a large patient population have shown that use of the anti-inflammatory and painkiller ibuprofen is linked to lower risk of developing Alzheimer's disease. Patients who used the drug for more than 5 years were 40 per cent less likely to develop the disease compared with patients who did not use that type of drug at all.

Sandra Day O'connor, Newt Gingrich Testify At Aging Hearing On Alzheimer's, USA

U.S. Senate Special Committee on Aging Chairman Herb Kohl (D-WI) held a hearing on Alzheimer's, a disease that currently affects over five million Americans and their families. Witnesses provided an update on the latest research and treatments, issues surrounding early-onset diagnoses, the importance of training and support for patient caregivers, and the need for a comprehensive strategy as more and more Americans are diagnosed with the disease.

First Conclusive Evidence Of Alzheimer's-Like Brain Tangles In Nonhuman Primates, Findings Could Pave Way For New Human Treatments

Researchers at the Yerkes National Primate Research Center, Emory University, have discovered the first conclusive evidence of Alzheimer's-like neurofibrillary brain tangles in an aged nonhuman primate.

Applied NeuroSolutions To Offer P-Tau 231 Test For Use In Alzheimer's Disease Clinical Trials

Applied NeuroSolutions, Inc. (OTC BB:APNS)( http://www.AppliedNeuroSolutions.com), a company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), today announced an initiative to provide its P-Tau 231 cerebrospinal fluid (CSF) test to companies undertaking AD clinical trials.

Alzheimer Scotland Supports Appeal Judgment On NICE Cost-effectiveness Disclosure

The Court of Appeal ruled in favour of the drug companies Pfizer and Eisai, by finding that the National Institute for Health and Clinical Excellence (NICE) should have allowed public access to the health economics model used to determine the cost-effectiveness of key treatments in people with early stage Alzheimer's.

Anti-Inflammatory Drug - Alzheimer's Society Comment

Alzheimer's Society comment on new research suggesting tarenflurbil may be effective in halting symptoms of Alzheimer's disease, from the Lancet Neurology. 'This exciting clinical trial suggests a modification of a safe and readily available anti-inflammatory drug has a positive impact on memory and function for people with mild Alzheimer's disease.

Seeing Alzheimer's Amyloids

In an important step toward demystifying the role protein clumps play in the development of neurodegenerative disease, researchers have created a stunning three-dimensional picture of an Alzheimer's peptide aggregate using electron microscopy. The study, in this week's issue of the Proceedings of the National Academy of Sciences, reports that researchers from Brandeis University in Waltham, Mass.

Risk Factors For Dementia Are Different Between Men And Women

According to a study published in the Journal of NeurologyNeurosurgery and Psychiatry, men and women have different risk factors that contribute to thedevelopment of Alzheimer's disease and dementia. The French researchersfoundthat stroke is a main risk factor for men and depression is a criticalfactor for women.

Renewed Hope For Mild Alzheimer's Patients As NICE Process On Anti-Dementia Medicines Ruled Unfair, UK

Eisai Limited, the licence holder of Aricept(R) (donepezil hydrochloride) and Pfizer Limited, its co-promotion partner, welcomed today's landmark ruling by the Court of Appeal. The Court found that the process by which the National Institute for Health and Clinical Excellence (NICE) decided to restrict anti-dementia medicines for newly diagnosed patients with mild Alzheimer's disease was procedurally unfair.

Alzheimer Scotland Welcomes Promising Early Findings From Tarenflurbil Study

Alzheimer Scotland welcomes the recent findings from Professor Gordon Wilcock's randomised phase II trial of tarenflurbil in patients with mild to moderate Alzheimer's Disease, but cautions that the phase III stage will be crucial in ascertaining its true potential.